Office of Research & Development |
|
Project Number: | I21HX003116-01A1 |
Title: | Assessment of cardiotoxicity in Immunity Checkpoint Blockers and other cancer therapies |
Principal Investigator: | Mary S. Vaughan-Sarrazin |
Location: | Iowa City, IA |
Congressional District Code: | 2 |
Research Service: | Health Services R&D |
Project Period: | September 2020 - August 2022 |
FY 2022 Funding Amount: | $58,125 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |